Why the study?
Does intravenous L-DOPA inhibit sympathetic and parasympathetic nerve function in cats and dogs pretreated with a monoamine oxidase inhibitor?
Population
Cats and dogs pretreated with a monoamine oxidase inhibitor
Design
Preclinical
Authors
Loading...
May warrant preclinical exploration of selective ganglionic modulation; leaves open any human cardiovascular relevance.
Does intravenous L-DOPA inhibit sympathetic and parasympathetic nerve function in cats and dogs pretreated with a monoamine oxidase inhibitor?
Intravenous L-DOPA inhibits sympathetic nerve function at the ganglionic level without affecting parasympathetic activity in animal models.
Antonaccio et al. (1974) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: